project id: TCGA-OV; case submitter id: TCGA-13-2057; source center: 22; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.1; rna integrity number: 7.0; spectrophotometer method: UV Spec; age at index: 59; days to birth: -21554; ethnicity: not reported; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 21554; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 2434.0; figo stage: Stage IIIC; icd 10 code: C56.9; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Ovary; synchronous malignancy: Not Reported; tissue or organ of origin: Ovary; tumor grade: Not Reported; year of diagnosis: 2008; alcohol history: Not Reported; is ffpe: false; weight: 168.0; composition: Not Reported; intermediate dimension: 1.5; longest dimension: 3.0; preservation method: Unknown; shortest dimension: 0.3; sample id: 7df2f2bf-f528-4e94-8241-f45d1f757d4a; sample submitter id: TCGA-13-2057-01A; portion id: 44c52f50-41dc-40d1-bdb6-f4e65f7defcd; portion submitter id: TCGA-13-2057-01A-02; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 50.0; percent tumor cells: 50.0; percent tumor nuclei: 90.0;